Liptruzet Interactions
There are 378 drugs known to interact with Liptruzet (atorvastatin/ezetimibe), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 45 are major, 299 are moderate, and 34 are minor.
- View all 378 medications that may interact with Liptruzet
- View Liptruzet alcohol/food interactions (2)
- View Liptruzet disease interactions (8)
Most frequently checked interactions
View interaction reports for Liptruzet (atorvastatin / ezetimibe) and the medicines listed below.
- alprazolam
- amlodipine
- aspirin
- bisoprolol
- carvedilol
- celecoxib
- chlorzoxazone
- ciprofloxacin
- Crestor (rosuvastatin)
- cyclobenzaprine
- Cymbalta (duloxetine)
- diclofenac
- duloxetine
- Effient (prasugrel)
- Farxiga (dapagliflozin)
- fluticasone
- fluticasone nasal
- furosemide
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- meloxicam
- metformin
- omeprazole
- tramadol
- Victoza (liraglutide)
- Vitamin D3 (cholecalciferol)
- Vytorin (ezetimibe / simvastatin)
- Zyrtec (cetirizine)
Liptruzet alcohol/food interactions
There are 2 alcohol/food interactions with Liptruzet (atorvastatin / ezetimibe).
Liptruzet disease interactions
There are 8 disease interactions with Liptruzet (atorvastatin / ezetimibe) which include:
- liver disease
- liver disease
- rhabdomyolysis
- myopathy/rhabdomyolysis
- renal impairment
- cognitive impairment
- diabetes
- renal disease
Report options
QR code containing a link to this page
More about Liptruzet (atorvastatin / ezetimibe)
- Liptruzet consumer information
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
